Serum sialic acid is a biologic marker for malignant disease

1 July 1983

journal article
research article
Published by Wiley in Journal of Surgical Oncology

Vol. 23 (3) , 163-166
https://doi.org/10.1002/jso.2930230307

Abstract

Serial serum sialic acid (N‐acetylneuraminic acid) was measured in 16 patients with advanced cancer of various histologic types. In the 15 evaluable patients serial changes in sialic acid correlated with the clinical course. Isolated sialic acid values were not predictive of clinical response. Serial determination of serum sialic acid appears to be a useful monitor of tumor burden.

Keywords

This publication has 8 references indexed in Scilit:

Glycoproteins and human cancer: II. Correlation between circulating level and disease status
Cancer, 1981
SIGNIFICANCE OF SIALIC-ACID AND CARCINOEMBRYONIC ANTIGEN AS MONITORS OF TUMOR BURDEN AMONG PATIENTS WITH CARCINOMA OF THE OVARY
1981
Serum sialic acid and CEA concentrations in human breast cancer
British Journal of Cancer, 1980
Glycoproteins and human cancer:1. Circulating levels in cancer serum
Cancer, 1979
Significance of protein-bound neuraminic acid levels in patients with prostatic and bladder carcinoma*
Urology, 1979
SERUM SIALIC-ACID AND SIALYLTRANSFERASE AS MONITORS OF TUMOR BURDEN IN MALIGNANT-MELANOMA PATIENTS
1979
Serum Sialic Acid Levels in Lung Cancer Patients
Pharmacology, 1976
The Sialic Acids
Journal of Biological Chemistry, 1971